Publication | Closed Access

Targeting cancer-associated fibroblasts by dual-responsive lipid-albumin nanoparticles to enhance drug perfusion for pancreatic tumor therapy

NanoparticlesNanomedicineDrug TargetingEngineeringTherapeutic NanomaterialsDual-responsive Lipid-albumin NanoparticlesPancreatic Tumor TherapyDrug PerfusionTumor TargetingNano-drug DeliveryBiomedical EngineeringRadiation Oncology